- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.11. | Catalent cuts 77 more jobs in Maryland as gene therapy resizing rolls on | ||
| 10.11. | Sanofi touts mission to 'chase the miracles of science' in new corporate campaign | ||
| 10.11. | Novo forges partnership with Emcure to expand Wegovy access in India | ||
| 10.11. | Pfizer's challenge of BridgeBio ads referred to federal agencies | ||
| 07.11. | J&J brings 'invisible illness' IBD out of the shadows with report supporting the power of patient community | ||
| 07.11. | Regeneron, AstraZeneca eye green lights after separate trial wins for Dupixent, Fasenra in inflammatory conditions | ||
| 07.11. | TV ad spending skyrocketed to new heights in October, led by record outlay for J&J's Tremfya | ||
| 07.11. | Gilead's Trodelvy stumbles in first-line breast cancer trial, adding to shaky clinical track record | ||
| 07.11. | Amid Metsera wrestling match, Novo CEO touts 'higher' bid and goads Pfizer | ||
| 07.11. | Merck Foundation pumps $22M into heart health equity programs | ||
| 07.11. | Fierce Pharma Asia-Lilly's AI drug design deal; Celltrion's autoimmune pact; China to lift Illumina ban | ||
| 06.11. | FDA approves J&J's Darzalex as 1st treatment for smoldering multiple myeloma | ||
| 06.11. | Providers' lawsuit against RFK Jr. now asks court to nullify ACIP's recent vaccine recommendations | ||
| 06.11. | FDA reveals 2nd round of 'national priority' voucher winners, including obesity giants Lilly and Novo | ||
| 06.11. | Without enough shareholder support, Bavarian Nordic's proposed private equity buyout fails | ||
| 06.11. | Eli Lilly, Novo Nordisk strike deals with White House to cut prices of weight loss drugs | ||
| 06.11. | AstraZeneca CEO: 'We can absorb the impact' of drug pricing deal with Trump | ||
| 06.11. | Incyte expands awards program to hidradenitis suppurativa ahead of FDA filing | ||
| 06.11. | Cencora earmarks $1B to expand US drug distribution operations | ||
| 05.11. | Supernus pauses new patient starts for Parkinson's pump Onapgo, citing high demand | ||
| 05.11. | Teva CEO touts 'defining strength' of innovative drugs as its sales grow for 11th straight quarter | ||
| 05.11. | Teva drafts NFL star Terrell Davis for tardive dyskinesia awareness drive | ||
| 05.11. | Madrigal reports sales boost for Rezdiffra while welcoming Novo to MASH market | ||
| 05.11. | AstraZeneca adds $136M investment to Chinese inhalants plant | ||
| 05.11. | After shaky Q3, Novo's new CEO says company's diabetes and obesity turnaround is a 'marathon, not a sprint' |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .